论文部分内容阅读
目的观察莫沙必利治疗功能性消化不良的临床疗效。方法采用随机对照研究,将86例功能性消化不良患者随机分为2组:治疗组44例,口服莫沙必利5mg/次,3次/d,共4周;对照组42例,口服多潘立酮10mg/次,3次/d,疗程4周。观察症状缓解情况,并作对比分析。结果治疗4周后,治疗组的有效率明显优于对照组,有显著差异(P<0.05)。结论莫沙必利治疗功能性消化不良疗效满意,且不良反应少。
Objective To observe the clinical efficacy of mosapride in treating functional dyspepsia. Methods A total of 86 patients with functional dyspepsia were randomly divided into two groups: treatment group (44 cases), oral mosapride 5 mg / time (n = 3) for 4 weeks, and control group (n = 42) 10mg / time, 3 times / d, treatment for 4 weeks. Observe the symptom relief, and make comparative analysis. Results After 4 weeks of treatment, the effective rate of the treatment group was significantly better than that of the control group, with significant difference (P <0.05). Conclusion Mosapride treatment of functional dyspepsia with satisfactory results, and less adverse reactions.